Dolutegravir intermediate-1 |
Catalog No.GC30687 |
Dolutegravir intermediate-1 is a synthetic intermediate of Dolutegravir extracted from patent WO 2016125192 A2.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1335210-23-5
Sample solution is provided at 25 µL, 10mM.
Dolutegravir intermediate-1 is a novel synthetic intermediate of dolutegravir extracted from patent WO 2016125192 A2. Dolutegravir is an integrase inhibitor developed for the treatment of human immunodeficiency virus (HIV)-l infection.
[1]. Sivaram Prasad, et al. Process for the preparation of dolutegravir . WO 2016125192 A2.
Average Rating: 5
(Based on Reviews and 20 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *